标题
Cannabidiol in the Treatment of Epilepsy
作者
关键词
-
出版物
CLINICAL DRUG INVESTIGATION
Volume 41, Issue 3, Pages 211-220
出版商
Springer Science and Business Media LLC
发表日期
2021-02-10
DOI
10.1007/s40261-021-01003-y
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Dose-Ranging Effect of Adjunctive Oral Cannabidiol vs Placebo on Convulsive Seizure Frequency in Dravet Syndrome
- (2020) Ian Miller et al. JAMA Neurology
- A Phase II Randomized Trial to Explore the Potential for Pharmacokinetic Drug–Drug Interactions with Stiripentol or Valproate when Combined with Cannabidiol in Patients with Epilepsy
- (2020) Elinor Ben-Menachem et al. CNS DRUGS
- Cannabidiol efficacy and clobazam status: A systematic review and meta‐analysis
- (2020) Simona Lattanzi et al. EPILEPSIA
- Does cannabidiol have antiseizure activity independent of its interactions with clobazam? An appraisal of the evidence from randomized controlled trials
- (2020) Meir Bialer et al. EPILEPSIA
- Cannabidiol in treatment of refractory epileptic spasms: An open-label study
- (2020) Aline Herlopian et al. EPILEPSY & BEHAVIOR
- A Phase 2, Double‐Blind, Placebo‐Controlled Trial to Investigate Potential Drug‐Drug Interactions Between Cannabidiol and Clobazam
- (2020) Kevan E. VanLandingham et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Plant derived versus synthetic cannabidiol: Wishes and commitment of epilepsy patients
- (2020) Randi von Wrede et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- Cognitive and behavioral effects of cannabidiol in patients with treatment-resistant epilepsy
- (2020) Birgitta Metternich et al. EPILEPSY & BEHAVIOR
- Long-term safety and efficacy of cannabidiol in children and adults with treatment-resistant Lennox-Gastaut syndrome or Dravet syndrome: Expanded access program results
- (2019) Linda C. Laux et al. EPILEPSY RESEARCH
- Cannabidiol in patients with Lennox-Gastaut syndrome: Interim analysis of an open-label extension study
- (2019) Elizabeth Thiele et al. EPILEPSIA
- Pharmacokinetics and Tolerability of Multiple Doses of Pharmaceutical-Grade Synthetic Cannabidiol in Pediatric Patients with Treatment-Resistant Epilepsy
- (2019) James W. Wheless et al. CNS DRUGS
- The Endocannabinoid System and Cannabidiol's Promise for the Treatment of Substance Use Disorder
- (2019) Yann Chye et al. Frontiers in Psychiatry
- Effects of cannabidiol on brivaracetam plasma levels
- (2019) Kerstin A. Klotz et al. EPILEPSIA
- fMRI study of cannabidiol-induced changes in attention control in treatment-resistant epilepsy
- (2019) Jane B. Allendorfer et al. EPILEPSY & BEHAVIOR
- Synthetic, non-intoxicating 8,9-dihydrocannabidiol for the mitigation of seizures
- (2019) Mark Mascal et al. Scientific Reports
- Drug–drug interactions and pharmacodynamics of concomitant clobazam and cannabidiol or stiripentol in refractory seizures
- (2019) Pavel Klein et al. EPILEPSY & BEHAVIOR
- Knowledge, expectations and fears of cannabis use of epilepsy patients at a tertiary epilepsy center
- (2019) Randi von Wrede et al. EPILEPSY & BEHAVIOR
- Synthetic pharmaceutical grade cannabidiol for treatment of refractory infantile spasms: A multicenter phase-2 study
- (2019) Shaun A. Hussain et al. EPILEPSY & BEHAVIOR
- The Endocannabinoid System and Synthetic Cannabinoids in Preclinical Models of Seizure and Epilepsy
- (2019) Anna-Maria Smolyakova et al. JOURNAL OF CLINICAL NEUROPHYSIOLOGY
- Efficacy and Tolerance of Synthetic Cannabidiol for Treatment of Drug Resistant Epilepsy
- (2019) Kerstin A. Klotz et al. Frontiers in Neurology
- Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial
- (2018) Philip McGuire et al. AMERICAN JOURNAL OF PSYCHIATRY
- Trends in resource utilization and prescription of anticonvulsants for patients with active epilepsy in Germany from 2003 to 2013 — A ten-year overview
- (2018) Laurent M. Willems et al. EPILEPSY & BEHAVIOR
- Open-label use of Highly* purified CBD (Epidiolex®) in patients with CDKL5 deficiency disorder and Aicardi, Dup15q, and Doose syndromes
- (2018) Orrin Devinsky et al. EPILEPSY & BEHAVIOR
- Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial
- (2018) Elizabeth A Thiele et al. LANCET
- Learning and memory is modulated by cannabidiol when administered during trace fear-conditioning
- (2018) A.L. Uhernik et al. NEUROBIOLOGY OF LEARNING AND MEMORY
- Randomized, dose-ranging safety trial of cannabidiol in Dravet syndrome
- (2018) Orrin Devinsky et al. NEUROLOGY
- Effect of Cannabidiol on Drop Seizures in the Lennox–Gastaut Syndrome
- (2018) Orrin Devinsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Circulating endocannabinoids and affect regulation in human subjects
- (2018) Emil F. Coccaro et al. PSYCHONEUROENDOCRINOLOGY
- The effects of cannabidiol (CBD) on cognition and symptoms in outpatients with chronic schizophrenia a randomized placebo controlled trial
- (2018) Douglas L. Boggs et al. PSYCHOPHARMACOLOGY
- Treatment Outcomes in Patients With Newly Diagnosed Epilepsy Treated With Established and New Antiepileptic Drugs
- (2018) Zhibin Chen et al. JAMA Neurology
- Long-Term Safety, Tolerability, and Efficacy of Cannabidiol in Children with Refractory Epilepsy: Results from an Expanded Access Program in the US
- (2018) Tristan T. Sands et al. CNS DRUGS
- Cannabidiol reduces seizures and associated behavioral comorbidities in a range of animal seizure and epilepsy models
- (2018) Pabitra Hriday Patra et al. EPILEPSIA
- Long-term cannabidiol treatment in patients with Dravet syndrome: An open-label extension trial
- (2018) Orrin Devinsky et al. EPILEPSIA
- Abuse potential assessment of cannabidiol (CBD) in recreational polydrug users: A randomized, double-blind, controlled trial
- (2018) Kerri A. Schoedel et al. EPILEPSY & BEHAVIOR
- Interactions between cannabidiol and commonly used antiepileptic drugs
- (2017) Tyler E. Gaston et al. EPILEPSIA
- Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection
- (2017) Evan C. Rosenberg et al. EPILEPSY & BEHAVIOR
- Labeling Accuracy of Cannabidiol Extracts Sold Online
- (2017) Marcel O. Bonn-Miller et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Evaluation of Cannabidiol in Animal Seizure Models by the Epilepsy Therapy Screening Program (ETSP)
- (2017) Brian D. Klein et al. NEUROCHEMICAL RESEARCH
- Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
- (2017) Orrin Devinsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cannabidiol attenuates seizures and social deficits in a mouse model of Dravet syndrome
- (2017) Joshua S. Kaplan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Protective Effects of Cannabidiol against Seizures and Neuronal Death in a Rat Model of Mesial Temporal Lobe Epilepsy
- (2017) Raquel A. Do Val-da Silva et al. Frontiers in Pharmacology
- Cannabidiol as a new treatment for drug-resistant epilepsy in tuberous sclerosis complex
- (2016) Evan J. Hess et al. EPILEPSIA
- Cannabidiol as a Potential Treatment for Febrile Infection-Related Epilepsy Syndrome (FIRES) in the Acute and Chronic Phases
- (2016) Jacqueline S. Gofshteyn et al. JOURNAL OF CHILD NEUROLOGY
- Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial
- (2016) Orrin Devinsky et al. LANCET NEUROLOGY
- Drug-drug interaction between clobazam and cannabidiol in children with refractory epilepsy
- (2015) Alexandra L. Geffrey et al. EPILEPSIA
- Parental reporting of response to oral cannabis extracts for treatment of refractory epilepsy
- (2015) Craig A. Press et al. EPILEPSY & BEHAVIOR
- Cannabinoids and Schizophrenia: Risks and Therapeutic Potential
- (2015) Marc W. Manseau et al. Neurotherapeutics
- Antidepressant-Like and Anxiolytic-Like Effects of Cannabidiol: A Chemical Compound of Cannabis sativa
- (2014) Alexandre Schier et al. CNS & Neurological Disorders-Drug Targets
- The case for medical marijuana in epilepsy
- (2014) Edward Maa et al. EPILEPSIA
- Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders
- (2014) Orrin Devinsky et al. EPILEPSIA
- ILAE Official Report: A practical clinical definition of epilepsy
- (2014) Robert S. Fisher et al. EPILEPSIA
- Cannabis, cannabidiol, and epilepsy — From receptors to clinical response
- (2014) Jerzy P. Szaflarski et al. EPILEPSY & BEHAVIOR
- Effects of intra-prelimbic prefrontal cortex injection of cannabidiol on anxiety-like behavior: Involvement of 5HT1A receptors and previous stressful experience
- (2013) M.V. Fogaça et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Cannabidiol enhances consolidation of explicit fear extinction in humans
- (2013) Ravi K. Das et al. PSYCHOPHARMACOLOGY
- Concentrations of Stiripentol in Children and Adults With Epilepsy
- (2012) Theodor W. May et al. THERAPEUTIC DRUG MONITORING
- Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naïve Social Phobia Patients
- (2011) Mateus M Bergamaschi et al. NEUROPSYCHOPHARMACOLOGY
- Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report
- (2010) José Alexandre S Crippa et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Cannabidiol injected into the bed nucleus of the stria terminalis reduces the expression of contextual fear conditioning via 5-HT1A receptors
- (2010) Felipe V Gomes et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action
- (2008) Antonio Waldo Zuardi REVISTA BRASILEIRA DE PSIQUIATRIA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now